INTRODUCTION
to decide which should be used for preparing the toxoid for human use, with the hope that the results could throw light on the mechanism of the tryptic activation.
Since the results with laboratory animals had demonstrated a much higher immunogenic efficiency of the toxoid derived from prototoxin (abbreviated to Proto-Td.) than that from the act. 12S toxin (Act.-Td.), we prepared a toxoid for human use from a highly purified preparation of prototoxin. This toxoid produced the antitoxin to satisfactorily high levels in human volunteers.
MATERIALS AND METHODS
Prototoxin and trypsin-activated I2S toxin: Partially purified prototoxin materials were prepared by the method described earlier (Sakaguchi, Sakaguchi and Imai, 1964) . The trypsin-activated materials were subjected to gel filtration on Sephadex G-200 to remove trypsin (Sakaguchi et al., 1964) . Both prototoxin and act. 12S toxin materials proved to be homogeneous in ultracentrifugal analyses with the same S20,w of 11.5 , but contained at least three distinct antigenic substances (Kitamura, Sakaguchi and Sakaguchi, 1967) .
Toxoids: Both prototoxin and act. 12S toxin were detoxified at pH near 6 with 0.2-0.4 % (v/v) f ormalin at 33 C. The detoxification test was carried out by injecting mice intraperitoneally with 0.5-ml doses. The toxoids were adsorbed onto either aluminum hydroxide or aluminum phosphate gel. Some properties of the toxoids used are shown in Table 1 . Determination of protein and nitrogen contents: Protein content was determined by the method of Lowry et al. (1951) with bovine serum albumin as standard. Protein nitrogen (N) was calculated by dividing the amount of protein by a factor of 6.25.
Determination of toxicity: Serial dilutions at 1.4-fold intervals were made in 0.05 M phosphate-buffered saline, pH 6.3, containing gelatin at 0.2 % (w/v). Half-ml doses of each dilution were injected intraperitoneally into 4 mice weighing 14-18 g. After 2 days, LD50 was calculated by the method of Reed and Muench (1938 Titration of antitoxin: To each tube containing an arbitrary test dose of a test toxin, was added the same volume each of serial dilutions of a serum sample. The mixtures were allowed to stand at room temperature for 60 min and each was injected intraperitoneally into 4 mice in a 0.5-ml dose. The antitoxin potency relative to that of the standard antitoxin was calculated after a 2 days' observation.
One test dose of the test toxin was defined as the amount which, when mixed with 0.01 IU of the standard antitoxin and injected intraperitoneally into mice, kills one-half group within 2 days.
RESULTS

Antitoxin-combining Power of Prototoxin and Act. 12S Toxin
The ratios of the L + doses of prototoxin to those of the act. 12S toxin at different test levels ranged from 1.1 to 4.0 (Table 2 ). In spite of the increase in toxicity by 250-fold, only little increase in the antitoxin-combining power resulted from the tryptic activation. Immune response of guinea pigs to two doses: The challenging method did not distinguish the antigenicities qualitatively nor did a single dose stimulate the animals to produce the antitoxin to a detectable level. Two injections were, therefore, given to guinea pigs to quantitate the antigenicities of Proto-Td. and Act.-Td.
Each of 40 guinea pigs in 4 groups received 2 subcutaneous injections at a 4-week interval.
The 1st group received 0.2 ml Proto-Td. (Lot 2); the 2nd 0.2 ml Act.-Td. (Lot 1); the 3rd 0.5 ml Proto-Td.; the 4th 0.5 ml Act.-Td.
All the animals were bled 2 weeks after the 2nd injection and the antitoxin titers determined with the results shown in Table 5 . Similar results were obtained in another experiment with Proto-Td. (Lot 3) and Act.-Td. (Lot 1). These results as well as the results shown in Table 5 are illustrated in Fig. 2 . Statistical analyses showed that the dose-response curves ran parallel with each other.
In the preceding experiments, Proto-Td. and Act. its trypsin-activated product (freed of trypsin) by formalinization and adsorption onto A1P04 gel under the same conditions. Two subcutaneous injections of either toxoid were given to guinea pigs at a 4-week interval.
The 1st group received 0.2 ml Proto-Td.; the 2nd 0.2 ml Act.-Td.; the 3rd 0.5 ml Proto-Td.; the 4th 0.5 ml Act.-Td.
Two weeks after the 2nd injection, blood samples were taken to be titrated for the antitoxin (Table 6) .
Proto-Td. produced the antitoxin to much higher levels than Act.-Td.
Immune response of rabbits to multiple doses: For primary immunization, three 0.2-m1 doses of Proto-Td. (Lot 4-a) and Act.-Td. (Lot 4-b) were injected subcutaneously every other days.
After a 4-week rest, two 0.4-m1 doses were injected at an interval of 3 days.
After another 3-week rest, additional three 0.5-m1 doses were injected at intervals of 10 and 14 days. Blood samples were taken at appropriate intervals.
The antitoxin titers are illustrated in Fig 3. The antitoxin was produced much earlier and the titer increased much more rapidly in the animals injected with Proto-Td. than those with Act.-Td.
In 11 weeks, the antitoxin titers reached 10, 14, 50 and 70 IU/ml in the former group; while in 13 weeks, the titers of the latter group were only 0.14, 1.4 and 1.4 IU/ml. The results with rabbits provided an additional evidence for the higher immunogenic efficiency possessed by Proto-Td. after the 2nd injection were lower than 0.01 IU/ml in 5 persons, 0.01 IU/ml in other 9, and higher than 0.01 IU/ml in another; those determined 2 weeks after the 3rd injection were 0.01-0.1 IU/ml in 4, 0.1-1 IU/ml in other 9, and 1 IU/ml or higher in the other 3. Thus, more satisfactory immunization was accomplished by prolonging the interval between the 2nd and the 3rd injections.
It is of fundamental importance to know the lowest antitoxin titer necessary to guarantee a complete protection against botulism hazard.
The monkeys containing an antitoxin titer of 2 IU/ml rendered by injection of the toxoid resisted the intraperitoneal challenge with act. 12S toxin containing as large as 1,000 monkey ip MLD, corresponding to 800,000 mouse ip LD50 (unpublished work). We consider, therefore, that the antitoxin titers attained by the volunteers, 0.1 IU/ml or higher, may be high enough to protect themselves from intoxication with botulinogenic food.
